论文部分内容阅读
目的探讨常规治疗加用低分子肝素对重度子痫前期的临床治疗效果。方法选取2013年1月至2013年12月封丘县人民医院收治的36例重度子痫前期患者,并根据治疗方法的差异将其分为观察组与对照组。对照组患者18例,以常规治疗法进行治疗;观察组患者18例,在常规治疗基础上联合低分子肝素对患者进行治疗。比较两组患者的临床治疗效果。结果观察组患者的治疗效果明显优于对照组患者,两组患者在治疗后的平均动脉压、24 h尿量、全血比黏度等方面比较差异有统计学意义(P<0.05)。结论在常规治疗基础上联合低分子肝素对重度子痫具有较好的临床治疗效果,且该种治疗方法不会对胎儿产生不良影响,安全性较高。
Objective To investigate the clinical effects of conventional treatment with low molecular weight heparin on severe preeclampsia. Methods Thirty-six patients with severe preeclampsia who were admitted to Fengqiu County People’s Hospital from January 2013 to December 2013 were selected and divided into observation group and control group according to the difference of treatment methods. The control group of 18 patients treated with conventional therapy; 18 patients in the observation group, on the basis of conventional treatment combined with low molecular weight heparin for treatment of patients. The clinical effects of the two groups were compared. Results The therapeutic effect of the observation group was significantly better than that of the control group. There was significant difference between the two groups in mean arterial pressure, 24 h urine output and whole blood viscosity after treatment (P <0.05). Conclusion Combined with low molecular weight heparin on the basis of routine treatment has a good clinical effect on severe eclampsia, and the treatment method will not have adverse effects on the fetus and is safe.